Carbon Dioxide Versus Air Insufflation in Oesophago-gastro-duodenoscopy (OGD)

Pain Clinical Trial

Official title:

A Double-blinded, Randomized Trial Comparing Carbondioxide(CO2)and Air Insufflation in Oesophago-gastro-duodenoscopy (OGD)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00627211
• Other study ID #: STHF Gastro BS1
• Status: Completed
• Phase: N/A
• First received: February 6, 2008
• Last updated: September 14, 2017
• Start date: February 2008
• Est. completion date: February 2009

Study information

• Verified date: September 2017
• Source: Norwegian Department of Health and Social Affairs
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Comparison on the effect on patient pain and discomfort by using CO2 instead of air for insufflation during gastroscopy.

Description:

To achieve a satisfactory examination of the GI tract it needs to be distended during endoscopic procedures. After the examinations many patients complain of abdominal pain and discomfort. This pain has been substantially reduced by substituting room air with CO2 in both colonoscopies and ERCPs. The use of CO2 during colonoscopy has become routine practice at many endoscopy centers.

In our study we will test the hypothesis that abdominal pain after gastroscopies also can be reduced by substituting room air with CO2.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 107
• Est. completion date: February 2009
• Est. primary completion date: February 2009
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients scheduled for OGD at the outpatient clinic of Telemark Hospital

Exclusion Criteria:

• Age <18

• Inability to give an informed concent

• Unsatisfactory norwegian language skills

• Patients not willing to participate

• COPD with dyspnoea NYHA 3-4

Related Conditions & MeSH terms

• Pain

Intervention

Procedure:
• CO2 insufflation
From the CO2 rack through the endoscopy rack CO2 will be insufflated to visualize the mucosa during oesophagogastroduodenoscopy.

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Norwegian Department of Health and Social Affairs

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Pain after OGD		0-48 hours
Secondary	Pain during OGD		24 hours